previously untreated patients who had anemia ( hemoglobin level , less than or equal to 10 g/dl ) caused by myelofibrosis ( mf ) ( 16 patients ) or other myeloproliferative disorders ( 13 patients ) were given the opportunity to participate in a prospective randomized study-to be treated either with 30 mg/day of oral fluoxymesterone and necessary transfusions or by transfusions alone .
C0001815
myelofibrosis
C0027022
myeloproliferative disorders